Veloce BioPharma Announces Positive Phase 2b Study Results for...
FORT LAUDERDALE, Florida, Oct. 3, 2018 /PRNewswire-AsiaNet/ -- -- Veloce BioPharma's VBP-926 (Povidone-Iodine) Demonstrates Statistically Significant and Clinically Significant Results in Phase 2b Study for Chemotherapy-Associated Paronychia-- Positive clinical results provide basis for pivotal Phase 3 cl...
Read more https://view-release/?pr-id=75556